Advertisement PDI gets $7.5 million sales contract - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

PDI gets $7.5 million sales contract

PDI, a provider of commercialization services to the biopharmaceutical industry has signed an agreement with a major pharmaceutical company for a new contract sales engagement.

The initiative will utilize PDI’s exclusive Select Access Team to reach pediatricians. The fee-for-service contract, commencing January 2008, is expected to generate approximately $7.5 million in revenue for PDI over its 12-month term.

Michael Marquard, PDI’s CEO, said: “Today’s marketplace demands significant flexibility and the selection of PDI showcases the importance of our sales services offerings to the industry. We are excited at the prospect of delivering exceptional results through exclusive promotion to pediatricians and look forward to a mutually successful endeavor.”